SCHEMBL27770442

SCHEMBL27770442

CC(C(=O)O)(c1ccc(O)cc1)C1CCCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM3 P20309 12/20 0.45
KEAP1 Q14145 1/20 0.45
NFE2L2 Q16236 1/20 0.45
CHRM2 P08172 6/20 0.42
CHRM4 P08173 6/20 0.42
CHRM1 P11229 6/20 0.42
ESR1 P03372 4/20 0.41
ESR2 Q92731 4/20 0.41
CYP3A4 P08684 3/20 0.41
ALDH1A1 P00352 3/20 0.41
HPGD P15428 2/20 0.41
LMNA P02545 1/20 0.41
TYR P14679 1/20 0.41
AR P10275 1/20 0.41
TSHR P16473 1/20 0.41
SLC6A2 P23975 1/20 0.41
SLC6A4 P31645 1/20 0.41
HTR6 P50406 1/20 0.41
ESRRG P62508 1/20 0.41
SLC6A3 Q01959 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4203042 0.86 KEAP1 (0.61) CHRM3KEAP1NFE2L2CHRM2CHRM4
SCHEMBL4203592 0.86 KEAP1 (0.61) CHRM3KEAP1NFE2L2CHRM2CHRM4
SCHEMBL4213705 0.86 KEAP1 (0.61) CHRM3KEAP1NFE2L2CHRM2CHRM4
SCHEMBL9899047 0.85 CHRM3 (0.44) CHRM3KEAP1NFE2L2CHRM2CHRM4
SCHEMBL3554824 0.85 CHRM3 (0.44) CHRM3KEAP1NFE2L2CHRM2CHRM4
SCHEMBL2788610 0.84 KEAP1 (0.59) CHRM3KEAP1NFE2L2CHRM2CHRM4
SCHEMBL14587261 0.82 KEAP1 (0.56) CHRM3KEAP1NFE2L2CHRM2CHRM4
SCHEMBL4426942 0.82 CHRM3 (0.42) CHRM3KEAP1NFE2L2CHRM2CHRM4
SCHEMBL16735582 0.79 EPHX2 (0.45) CHRM3CHRM2CHRM4CHRM1ALDH1A1
SCHEMBL4243455 0.78 KEAP1 (0.50) CHRM3KEAP1NFE2L2CHRM2CHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101490003-A New alkyl esters of cyclic amino alcohols with muscarinic m3 receptor antagonist activity, useful for treating e.g. chronic bronchial obstruction, asthma and overactive bladder ASTRAZENECA AB (SE) 2009-07-22 CN disclosed